About InCellDx
InCellDx is a private company based in Hayward, California. It has reported $9,499,998 raised in three offerings on Form D since June 2010.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 16, 2024 | Jul 23, 2024 | $500,000of $13.5M target | 1 | $500K | EquityRule 506(b) | Form D ↗ |
| Apr 27, 2012 | May 14, 2012 | $5,999,998of $7.1M target | 1 | $5.9M | Equity, Options, Securities on exercise06 | Form D ↗ |
| Jun 4, 2010 | Jun 17, 2010 | $3,000,000fully sold | 2 | $1.5M | Equity, Series A Preferred Stock, including the shares of Common Stock issuable upon conversion of the Series A Preferred Stock.06 | Form D ↗ |
| Total, three offerings | $9,499,998 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on InCellDx's Form D filed Jul 23, 2024.
Earlier filings also listed Thaddeus Taube (director, last listed May 2012), Marc Grodman (director, last listed May 2012), Lowell Gruman (executive director, last listed May 2012), Eric Hass (executive officer, last listed May 2012), Charles Todd (director, last listed May 2012), Linda Law (director, last listed Jun 2010) and Carol Penfold-Patterson (chief financial officer and treasurer, director, last listed Jun 2010).